Background: Epicardial adipose tissue (EAT) is a visceral adipose tissue surrounding the heart and the coronary arteries. Because of its endocrine and paracrine activity, secreting pro-inflammatory and antiinflammatory cytokines and chemokines, it has been suggested to influence coronary atherosclerosis development. Objectives: To identify the relationship between echocardiographic epicardial fat thickness and the extent of coronary artery disease (CAD). 
Introduction
Different types of adipose tissue, particularly subcutaneous and visceral adipose depots, are now recognized as having distinct quantitative characteristics. 1, 2 Visceral adiposity is a fat deposition around internal organs. It is metabolically active. 3 It is strongly correlated with diabetogenic features (e.g., impaired insulin sensitivity, increased insulin levels), (Bangladesh Heart Journal 2018; 33(1) : [47] [48] [49] [50] [51] [52] [53] atherogenic features (e.g., increased triglycerides, decreased high density lipoproteins), prothrombotic factors (e.g., increased fibrinogen, Factor VII, plasminogen activator inhibitor-1) and proinflammatory cytokines (e.g., interleukin-6 [IL-6] and tumor necrosis factor-a [TNF-a]). 4 Epicardial adipose tissue (EAT) is considered as visceral fat deposited around the heart, particularly around epicardial coronary vessels. Epicardial fat may directly affect the coronary arteries and myocardium through paracrine actions of locally secreted adipocytokines and other bioactive molecules, contributing to the development of coronary artery disease (CAD). 5 It is increasingly evident that visceral adipose tissue (VAT) is an important CAD risk factor. 6, 7 Recently, it was reported that EATmeasured by transthoracic echocardiography was well correlated with abdominal VAT assessed by MRI and computed tomography and that echocardiographic EAT thicknesscould be used as a reliable imaging indicator of VAT. 8, 9 Epicardial fat defined as an echo-free space between the outer wall of the myocardium and the visceral layer of pericardium. 10 The highest diameter of this fat is on right ventricular free wall. Transthoracic echocardiography provides a reliable measurement of epicardial fat thickness (EFT). 3 The subcostal four chamber and parasternal long and short axis echocardiogram views show this finding in best way. 11,12 A normal upper-limit value for EFT has not been established yet. 13 Although epicardial fat is readily visualized on high speed CT and MRI, widespread use of these methods for its assessment is not practical. In this context, Echocardiographic assessment of EAT could be a simple and practical tool for cardiovascular risk stratification in clinical practice and research.The general objective of this study was to identify the relationship between echocardiographic epicardial fat thickness and the extent of coronary artery disease. There were some specific objectives also, i.e., to measure epicardial fat thickness by transthoracic echocardiography; to measure the severity of coronary artery disease by CAG; to establish echocardiographicepicardial fat thicknessmeasurement as a simple, non-invasive, time efficient and reliable imaging indicator for cardiovascular risk
Methods:
This was a cross-sectional analytical study conducted in the Department of Cardiology, Dhaka Medical College&Hospital over a period of one year (July, 2015 to June 2016) on 87 purposively sampled patients with myocardial infarction, unstable angina and stable angina who underwent echocardiography and CAG and who fulfilled the inclusion and exclusion criteria. To minimize the confounding effects, the following patients were excluded from the study, i.e., pericardial effusion, abnormal images on transthoracic echocardiography or poor echo window, history of coronary artery bypass graft surgery (CABG), history of percutaneous coronary intervention (PTCA), cardiomyopathy, severe comorbidities-like malignancy, chronic kidney disease, patients unwilling to given consent, moderate to severe degree of valvular heart disease, etc.
Prior to the commencement of this study, the research protocol was approved by the Research Review Committee of Department of Cardiology and the Ethical Committee of DMCH, Dhaka. Detailed history, clinical examination and relevant investigation reports of all patients were recorded in pre-designed data collection sheet at the beginning of the study. Cardiac catheterizations and coronary angiography was performed using the Judkin's technique. All standard views were taken. In selected cases additional views were taken. CAG was analyzed by visual estimation. 70% or more luminal stenosis was considered significant except in left main coronary artery lesion where 50% or more luminal stenosis was considered significant. The reporters of CAG had no prior knowledge of the echocardiographic findings.The report was defined as single vessel disease, double vessel disease and triple vessel disease as followsi) Single-vessel disease: Presence of ≥70% diameter lumen narrowing in either the left anterior descending, left circumflex or right coronary artery or a major branch. ii) Double-vessel disease: Presence of ≥70% diameter lumen narrowing in two of the three major epicardial vessel systems. iii) Threevessel disease: Presence of ≥70% diameter lumen narrowing in all three major epicardial vessel systems. Each patient underwent transthoracic echocardiography (TTE) by Vivid 7 (GE, USA) in the left lateral decubitus position the next day after CAG. EAT thickness was measured on the free wall of right ventricle from the parasternal long-axis views. EAT was identified as the anterior echo-lucent space between the outer wall of the myocardium and the visceral layer of pericardium on the two-dimensional echocardiography and its thickness was measured in still images on the free wall of the right ventricle along the midline of the ultrasound beam with best effort to be perpendicular to the aortic annulus in parasternal long axis view, at enddiastole for 3 cardiac cycles. The average value from 3 cardiac cycles for each echocardiographic view was used for the statistical analysis. The offline measurement of EAT thickness was performed by two cardiologists, expert in echocardiography who would be unaware of the clinical and angiographic findings.All the data were compiled duly in the data collection sheet for statistical analysis and interpretation. Fig-1 : Example of measurement of epicardial fat thickness (EAT). Epicardial fat was identified as an echo-free space in the pericardial layers on the 2-dimensional echocardiography and its thickness was measured perpendicularly on the free wall of the right ventricle at enddiastole. 
Results:
A total 87 patients were selected for the study of which 67 had CAD and 20 had normal coronary angiogram. Baseline characteristics, risk factors for CAD and echocardiographic EAT thickness were compared and presented in different tables and figures below. Table-I shows that patients with CAD were older. Mean age was 53.25±10.27 years in patients with CAD and 46.80±8.25 years in patients without CAD (p=0.012). Male (77.6%) was predominant in patients with coronary artery disease, but in patients without coronary artery disease, female (65.0%) was found as predominant gender. The mean EAT thickness of the patients was 6.44±2.11 mm (range 2.20-11.0 mm). It was significantly thicker in patients with CAD (7.14±1.81mm) than those without CAD (4.08±1.06mm) (p=<0.001).
Diabetes mellitus anddyslipidemia were more common in patients with significant coronary artery disease (p<0.05). There was no significant inter group difference on smoking, hypertension and BMI (p>0.05). Waist circumference were statistically significant in patients with CAD (p =0.009). Table II shows the distribution of EAT between male and female patients, mean EAT was 6.81±1.94 in male and The data of echocardiographic EAT thickness were arranged in quartiles and the incidence of CAD was assessed which are showed in Table- 
Discussion:
This cross sectional, analytical study was conducted on 87 patients with established or suspected coronary artery disease who were admitted to Department of Cardiology of Dhaka Medical College &Hospital, Dhaka and underwent coronary angiogram. After exclusion, a total 87 patients were included. Echocardiographic measurement of epicardial adipose tissue (EAT) thickness was done accordingly after admission. Based on coronary angiogram, 67 patients had coronary artery disease (CAD) and 20 patients had normal coronary angiogram.
In this study, mean EAT thickness was found 6.44±2.11 mm. EAT thickness may be different according to the race. In a study in USA, conducted by lacobellis et al. 13 median values of EAT thickness was 9.5 mm in men and 7.5 mm in women. Mean EAT thickness was found 6.1 mm in a study conducted by Sadeaet al. 14 on European population. Mean EAT thickness was found 6.3 mm in a study conducted by jeong et al 15 . In this study the EFT in CAD group was significantly higher than in normal group (7.14±1.81 mm vs 4.08±1.06 mm, p<0.001). These findingsare consistent with study of Shimiraniet al 3 who found significantly higher the EFT in CAD group than in normal group (5.4±1.9 mm vs 4.4±1.8mm, p=0.0001).We found EATto be thicker in men than in women (6.81±1.94 mm vs 5.58±2.27 mm; p =0.012), which was consistent with the study of Sadea et al. 14 whereEAT was also found significantly thicker in men than in women (6.5± 1.6mm vs 5.5± 1.8mm; P<0.001). But, Ahn et al 16 . did not find any difference of EAT thickness between men and women.
EAT thickness showed definite relationship with some clinical and biochemical parameters. In this study, shows a significant positive correlation between EAT thickness and age (r=0.373, p<0.001), BMI (r=0.275, p=0.01), waist circumference (r=0.471, p<0.001), TC (r=0.272, p=0.011), TG (r=0.305, p=0.004) and LDL (r=0.271, p=0.011) and inversely correlated with HDL-C (r=-0.298, p=0.005). Ahnet al 16 . revealed similar findings in their study.Shemiraniet al. 3 found that EFT had a positive correlation with LDL, BMI (p=0.001), serum triglyceride (p=0.04) and WC (p=0.04), which correlate with this study.Jeonget al 15 . stated a significant correlation was revealed between EAT and age (r=0.332, p<0.001), body mass index (r=0.142, p=0.044) and waist circumference (r=0.229, p=0.001).
In this study, significant CAD was found in 60% patients in 1 st quartile, 69.6% patients in 2 nd quartile, 82.6% patients in 3 rd quartile and 95.2% patients in 4th quartile of EAT thickness. The increasing percentage of CAD in higher quartiles was significant (p<0.039). This finding was consistent with those of some previous studies, which also showed that EAT was significantly thicker in subjects with CAD than those without CAD. 14, 15 EAT thickness showed significant variation among patients with normal/non-significant CAD, single vessel CAD, double and triple vessel CAD. The thickness was 4.08±1.06 mm in patients with normal/non-significant CAD (n=20), 5.75±0.96 mm in single vessel CAD (n=24), 6.54±1.09 mm in double vessel CAD (n=16) and 8.75±1.45 mm in patients with triple vessel CAD (n=27) in this study. This increasing thickness of EAT in more severe form of coronary artery disease was statistically significant (p <0.001). This finding of correlation between EAT thickness and the severity of CAD was compatible with that of previous two studies. 14 
Conclusion:
Epicardial adipose tissue (EAT) thickness, which can easily be and non-invasively evaluated by transthoracic echocardiography, is significantly higher in patients with angiographically detected coronary artery disease in comparison to those with normal coronary arteries. Furthermore, EAT thickness increases with the severity of coronary artery disease; i.e it is thicker in multivessel coronary artery disease than in single vessel or nonsignificant coronary artery disease.
Study limitations
There may be selection bias because this study included only those patients pre-selected to undergo coronary angiography.As epicardial adipose tissue has a threedimensional (3D) distribution, two dimensional (2D) echocardiography may not assess the total amount of epicardial adiposity completely. Epicardial adipose tissue thickness can be measured as a mean of values from parasternal long axis and short axis views.In this study, the value measured from the parasternal long axis view was used. A large, prospective, cohort study might be necessary to elucidate the clinical significance of epicardial adipose tissue (EAT) thickness in the general population.
